Research to Prevent Blindness

New Findings on Blood Vessel Regulation

Gregory Schwartz, PhD, an RPB Career Development Award recipient, and his research collaborators at Northwestern University School of Medicine, recently published important discoveries related to blood vessel regulation in the journal Neuron. They identified nitric oxide-releasing amacrine cells as critical to blood vessel regulation in the retina and beyond.

The findings could impact diseases involving blood flow, such as diabetic retinopathy (DR). By detecting damage to nitric oxide-releasing amacrine cells, DR could potentially be diagnosed years earlier than is currently possible—before damage occurs. The knowledge gained through this research could even lead to new options for stroke treatment.

Read the full news story from Northwestern Medicine

top

November 27, 2018

Diabetic Retinopathy

Feature Story

Retina Disorders

stroke

Top Story

Related News: Diabetic Retinopathy, Feature Story, Retina Disorders , stroke, Top Story

RPB-SUPPORTED RESEARCHERS INTEGRAL TO NEI’S AUDACIOUS GOALS INITIATIVE

Vision scientists who have received RPB funding will help lead all five research teams, which will seek to accelerate development of regenerative treatments for blindness.

EMERGING VISION SCIENTISTS EDUCATE, THANK CONGRESS FOR RESEARCH APPROPRIATIONS

(NAEVR) held its Fourth Annual Emerging Vision Scientists (EVS) Day on Capitol Hill and twenty early-stage investigators participated.

RPB AND LCIF TO CONTINUE LOW VISION RESEARCH AWARD PARTNERSHIP

Research to Prevent Blindness (RPB) and Lions Clubs International Foundation (LCIF) announced today that they will continue their partnership in the RPB/LCIF Low Vision Research Award.

RPB researchers honored with 2018 António Champalimaud Vision Award

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research

IN THE FUTURE, ALZHEIMER’S MAY BE PREDICTED DURING EYE EXAMS

RPB-funded researchers at Washington University School of Medicine in St. Louis (WUSTL) have found a correlation in 30 older patients between retina thinning and elevated levels of tau and amyloid proteins that are the hallmark of Alzheimer’s disease.